| Shree Ganesh Remedies Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 540737 |
NSE Symbol : - |
P/E(TTM) : 28.62 |
|
ISIN Demat : INE414Y01015 |
Div & Yield% : 0.00 |
EPS(TTM) : 15.92 |
|
Book Value(₹) : 119.62 |
Market Cap(₹Cr) : 584.88 |
Face Value(₹) : 10.00 |
| Particulars | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|
| Gross Sales | 30.32 | 24.67 | 24.43 | 27.05 | 32.33 | 24.78 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 30.32 | 24.67 | 24.43 | 27.05 | 32.33 | 24.78 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 0.69 | 0.66 | 2.29 | 0.71 | 0.19 | 0.54 |
| Total Income | 31.00 | 25.33 | 26.72 | 27.76 | 32.52 | 25.32 |
| Total Expenditure | 20.70 | 17.37 | 14.55 | 17.15 | 21.02 | 16.66 |
| PBIDT | 10.31 | 7.96 | 12.16 | 10.61 | 11.50 | 8.67 |
| Interest | 1.01 | 0.94 | 0.96 | 0.38 | 0.43 | 0.32 |
| PBDT | 9.30 | 7.02 | 11.21 | 10.24 | 11.07 | 8.35 |
| Depreciation | 2.59 | 2.42 | 2.42 | 2.70 | 2.42 | 2.02 |
| Tax | 1.54 | 1.02 | 2.26 | 2.08 | 2.24 | 1.66 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 0.22 | 0.13 | -0.08 | 0.02 | -0.01 | 0.03 |
| Reported Profit After Tax | 4.96 | 3.45 | 6.60 | 5.43 | 6.42 | 4.65 |
| Extra-ordinary Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | 4.96 | 3.45 | 6.60 | 5.43 | 6.42 | 4.65 |
| EPS (Unit Curr.) | 3.86 | 2.69 | 5.13 | 4.23 | 4.98 | 3.62 |
| EPS (Adj) (Unit Curr.) | 3.86 | 2.69 | 5.13 | 4.23 | 4.98 | 3.62 |
| Calculated EPS (Unit Curr.) | 3.86 | 2.69 | 5.14 | 4.23 | 5.00 | 3.62 |
| Calculated EPS (Adj) (Unit Curr.) | 3.86 | 2.69 | 5.14 | 4.23 | 5.00 | 3.62 |
| Calculated EPS (Ann.) (Unit Curr.) | 15.44 | 10.75 | 20.56 | 16.93 | 19.98 | 14.49 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 15.44 | 10.75 | 20.56 | 16.93 | 19.98 | 14.49 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 12.84 | 12.84 | 12.84 | 12.84 | 12.84 | 12.84 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 34.00 | 32.27 | 49.77 | 39.22 | 35.57 | 34.99 |
| PBDTM(%) | 30.67 | 28.46 | 45.89 | 37.86 | 34.24 | 33.70 |
| PATM(%) | 16.36 | 13.98 | 27.02 | 20.07 | 19.86 | 18.77 |